Suppression of serotonergic neuronal firing by alpha-adrenoceptor antagonists: evidence against GABA mediation

European Journal of Pharmacology
J M Baraban, G K Aghajanian

Abstract

Recent pharmacological studies have shown that administration of alpha-adrenoceptor antagonists, either systemically or locally in the vicinity of 5-HT cells of the dorsal raphe, suppresses their firing activity. In light of the prominent NE innervation of the dorsal raphe nucleus, these findings suggest that blockade of NE transmission in the dorsal raphe by these drugs underlies the suppression produced. The finding that systemic administration of picrotoxin, a GABA antagonist, partially reverses the suppression of 5-HT cells produced by systemic application of alpha-adrenoceptor antagonists led to the proposal that GABA interneurons located within the dorsal raphe mediate this suppression of 5-HT cell firing. This proposal has been tested, in this study, by examining the ability of two GABA antagonists, picrotoxin and bicuculline methiodide, when applied iontophoretically to reverse the suppression produced by two alpha-adrenoceptor antagonists, WB-4101 and phentolamine. First, evidence is presented that WB-4101 and phentolamine suppress 5-HT cell firing specifically by their blockade of alpha-adrenoreceptors. Second, the inability of both GABA antagonists tested to interfere with the suppression produced by these alpha-adre...Continue Reading

References

Oct 1, 1976·European Journal of Pharmacology·D W Gallager, G K Aghajanian
Jun 15, 1979·Brain Research·R B McCall, G K Aghajanian
Nov 1, 1978·European Journal of Pharmacology·J M BarabanG Aghajanian
May 25, 1979·Brain Research·E G McGeerE A Singh
Apr 10, 1965·Nature·R C Thomas, V J Wilson
Jul 20, 1972·Brain Research·S F Pong, L T Graham
Dec 13, 1972·Nature: New Biology·G A JohnstonR M Maclachlan
Jul 1, 1972·Life Sciences. Pt. 1: Physiology and Pharmacology·G K AghajanianF E Bloom
Oct 1, 1973·Journal of Neurochemistry·G Svenneby, E Roberts
Jan 1, 1968·Experimental Brain Research·D R CurtisG A Johnston
Feb 9, 1965·Zeitschrift für Zellforschung und mikroskopische Anatomie·K FUXE
Jun 1, 1976·Neuroscience Letters·S S Mosko, B L Jacobs

❮ Previous
Next ❯

Citations

May 1, 1993·Naunyn-Schmiedeberg's Archives of Pharmacology·T JolasM Hamon
Jan 1, 1990·Journal of Neural Transmission. General Section·B Söderpalm, J A Engel
Jan 1, 1995·Journal of Neural Transmission. General Section·A SöderpalmB Söderpalm
Sep 25, 1999·European Journal of Pharmacology·T J ConnorB E Leonard
Jun 24, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francis Rodriguez BambicoGabriella Gobbi
Apr 3, 1999·British Journal of Pharmacology·S T SzaboP Blier
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Xing SunJimo Borjigin
Nov 1, 1984·Clinical and Experimental Pharmacology & Physiology·M A NelsonB A Scoggins
Oct 15, 2008·Expert Opinion on Therapeutic Targets·Francis Rodriguez Bambico, Gabriella Gobbi
Nov 8, 2011·The International Journal of Neuropsychopharmacology·Benoit LabonteGabriella Gobbi
Mar 23, 2005·Neuroscience Letters·Naoya KawashimaAtsuro Nakazato
Jun 27, 2007·Experimental Physiology·P L Cedraz-MercezL C Reis
Jul 1, 1983·The International Journal of Neuroscience·J S Richardson, E K Chiu
Sep 15, 2005·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Nathalie BockAribert Rothenberger
Jan 15, 1996·The Journal of Comparative Neurology·C PeyronM Jouvet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.